Embecta to Acquire Owen Mumford Holdings for Up to £150 Million

Embecta Corp. has entered a definitive agreement to acquire Owen Mumford Holdings Limited, a UK-based medical device and drug-delivery technology innovator, for up to £150 million. The deal includes a £100 million upfront payment and up to £50 million in performance-based payments based on net sales of Owen Mumford's Aidaptus auto-injector platform. The acquisition is expected to improve Embecta's revenue growth trajectory and accelerate its strategic transformation into a broad-based medical supplies company.